The concept of the neural-immune-cardiovascular axis embodies a sophisticated, multidirectional communication network integrating the nervous system, immune responses, and cardiovascular function. Conditions such as Takotsubo syndrome, triggered by emotional stress, illustrate the direct impact of the nervous system on heart pathology. This axis challenges traditional views of cardiovascular disease by emphasizing the brain’s regulatory role and the immune system’s involvement beyond local vascular pathology. Dysregulation of this axis contributes to the development and progression of major cardiovascular diseases, underscoring the necessity of an integrative approach to pathogenesis and treatment.
The axis comprises neural outputs, immune mediators, and the vascular system functioning in concert to regulate cardiovascular health. Central to communication are neurotransmitters, neuropeptides, cytokines, and endocrine factors allowing dynamic interactions between these systems.
Sympathetic nervous system (SNS) activity predominantly influences cardiovascular and immune functions through norepinephrine (NE) release impacting adrenergic receptors on various cells. This modulation alters cytokine production, vascular smooth muscle tone, and immune polarization. Parasympathetic input via the vagus nerve releases acetylcholine (ACh), acting on nicotinic and muscarinic receptors to suppress inflammation and promote vasodilation. Sensory neurons provide afferent signals to the central nervous system and efferently modulate local vascular and immune responses through neuropeptides such as substance P and calcitonin gene-related peptide. The hypothalamic-pituitary-adrenal (HPA) axis adds a neuroendocrine dimension by releasing glucocorticoids that broadly regulate immune and vascular functions, linking psychosocial stress to cardiovascular pathology.
Immune cells actively participate in bidirectional communication with neural pathways. Expression of receptors for neurotransmitters and neuropeptides on innate and adaptive immune cells enables these cells to respond differentially to neural signals, shifting between pro- and anti-inflammatory states. Cytokines released by immune cells, including TNF-α, IL-1β, and IL-6, influence vascular cells and modulate neural activity through feedback mechanisms. The spleen functions as a neuroimmune hub where sympathetic innervation affects immune cell distribution and inflammatory profile, impacting cardiovascular disease progression. Adaptive immunity, especially T cell subsets, is shaped by neural signaling, influencing inflammatory responses crucial to disease pathogenesis.
The vascular system integrates incoming neural and immune signals, regulating hemodynamics, endothelial permeability, vascular remodeling, and inflammation. These coordinated responses affect tissue perfusion and contribute to pathological vascular changes in cardiovascular diseases.
Within atherosclerosis, neuroimmune interactions in the arterial adventitia form specialized interfaces where nerve fibers and immune cells engage in disease-promoting crosstalk. Sympathetic activation enhances inflammatory responses, endothelial dysfunction, and plaque progression. Disruption of these neuroimmune circuits has shown potential to mitigate atherosclerotic disease.
Hypertension is driven by immune cell infiltration and cytokine release in vascular and renal tissues alongside increased sympathetic tone. Chronic activation of the neuroimmune axis induces vascular resistance and remodeling, exacerbating blood pressure elevation and disease progression.
In heart failure, persistent neuroimmune activation sustains inflammation and adverse cardiac remodeling. Feedback loops involving cytokines and sympathetic signaling perpetuate dysfunction, demonstrating the axis’s role in disease exacerbation and symptomology.
Emerging therapies aim to modulate components of the neuroimmune axis, including sympathetic blockade, vagus nerve stimulation, and cytokine targeting. These interventions seek to restore immune balance and improve cardiovascular outcomes but require further clinical evaluation.
Challenges in targeting this axis include its complexity, pleiotropic receptor signaling, and systemic effects. Future research must better elucidate mechanistic pathways, identify biomarkers, and develop selective therapies that modulate specific neuroimmune components without adverse consequences.
The neural-immune-cardiovascular axis represents a fundamental regulatory system in cardiovascular health and disease. Understanding its intricate mechanisms affords novel insights into cardiovascular pathogenesis and opens avenues for innovative therapies addressing the multi-system nature of cardiovascular diseases.